Amendment and Mail Process Complete

ESCOZINE HP

Medolife Corporation

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88300517 FILING DATE 02/13/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY EDWARDS, ALICIA COLLIN
L.O. ASSIGNED 115

PUB INFORMATION

RUN DATE 11/22/2019
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 11/21/2019
LITERAL MARK ELEMENT ESCOZINE HP

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) YES 1 (a) YES 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ESCOZINE HP
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Medolife Corporation
ADDRESS 433 N Camden Dr
Beverly Hills, CA 90210
ENTITY 03-CORPORATION
CITIZENSHIP Wyoming

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Homeopathic pharmaceuticals for use in the treatment of pain, inflammation, low appetite, low energy, and poor sleep

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 09/30/2016 FIRST USE IN COMMERCE DATE 10/03/2016 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DISCLAIMER W/PREDETER TXT "HP"
DESCRIPTION OF MARK The mark consists of the word "Escozine" in capital letters, and the abbreviation "HP" in capital letters inside a colored box directly below.????
TRANSLATION The wording "Escozine-HP" has no meaning in a foreign language.
OWNER OF US REG NOS 5007587   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
11/21/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 011
11/21/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 010
11/15/2019 ALIE A ASSIGNED TO LIE 009
11/07/2019 ALIE A ASSIGNED TO LIE 008
10/31/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
05/02/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
05/02/2019 GNRT F NON-FINAL ACTION E-MAILED 005
05/02/2019 CNRT R NON-FINAL ACTION WRITTEN 004
04/24/2019 DOCK D ASSIGNED TO EXAMINER 003
03/07/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
02/16/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY NONE
CORRESPONDENCE ADDRESS MEDOLIFE CORPORATION
MEDOLIFE CORPORATION
433 N CAMDEN DR
BEVERLY HILLS, CA 90210
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed